Longer Infusion Site Lifetime with NovoLog Reported
In a letter to the editors of Diabetes Care entitled Pediatric Use of Insulin Pumps: Longer Infusion Site Lifetime with NovoLog (Diabetes Care 2002 Sep;25(9):1663), Denis Becker, MD, reports a case history of a 12-year-old boy with type 1 diabetes who switched to NovoLog insulin and experienced a significant increase in infusion set life, from 1-2 days with Humalog to 4-5 days with NovoLog. Dr. Becker notes that "Although the mechanism for improved infusion site duration with insulin aspart [NovoLog, Ed.] is not known, the response is consistent over the lifetime of the infusion site, and has not been accompanied by an increased frequency of hypoglycemia."
Kids and adults using insulin pumps who are experiencing short infusion set life may wish to discuss this letter with their diabetes team.
12 September 2002
Last Updated: Thursday September 12, 2002 19:16:44
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2014. Comments and Feedback.